insitro News

Insitro secures AstraZeneca collaboration for AI discovery in liver and heart disease

Insitro and AstraZeneca announced an AI drug discovery collaboration on October 15 targeting metabolic dysfunction-associated steatohepatitis (MASH) and cardiomyopathies. Insitro will receive $40 mill...